Medtech Companies Rally After Data on Weight Loss Drug

  • 📰 Reuters
  • ⏱ Reading Time:
  • 9 sec. here
  • 10 min. at publisher
  • 📊 Quality Score:
  • News: 35%
  • Publisher: 97%

Finance News

Medtech,Weight Loss Drug,S&P 500

The S&P 500 closed slightly lower as investors awaited crucial inflation data that could impact the U.S. Federal Reserve's interest rate decisions. The focus shifted to the Consumer Price Index (CPI) data, with economists expecting a 3.3% increase for October. Core prices are expected to remain unchanged. The CPI reading, along with the labor market, will determine the future of Fed policy.

The S&P 500 closed slightly lower as investors awaited crucial inflation data that could impact the U.S. Federal Reserve's interest rate decisions. The focus shifted to the Consumer Price Index (CPI) data, with economists expecting a 3.

3% increase for October. Core prices are expected to remain unchanged. The CPI reading, along with the labor market, will determine the future of Fed policy.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in MY

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines